Fundraising FoxPharming Group
1 known investors
Find your way into Pharming Group
Sign up to find every way you can get introduced to Pharming Group
- Your email: who you already know at Pharming Group, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Pharming Group team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Pharming is an integrated biotechnology company that develops and delivers targeted therapies for rare and ultra-rare immunological and genetic diseases, including hereditary angioedema (HAE), activated PI3K delta syndrome (APDS), and primary mitochondrial disease (PMD). It spans clinical development, manufacturing, regulatory affairs, and commercialization for the rare disease community.
Investors · 1
Frequently asked questions
- What does Pharming Group do?
- Pharming is an integrated biotechnology company that develops and delivers targeted therapies for rare and ultra-rare immunological and genetic diseases, including hereditary angioedema (HAE), activated PI3K delta syndrome (APDS), and primary mitochondrial disease (PMD). It spans clinical development, manufacturing, regulatory affairs, and commercialization for the rare disease community.
- Who are Pharming Group's investors?
- Pharming Group's investors include Sequoia Capital.